Aoife Delmas, European Society of Cardiology, Katie Koziol and Andrew Moore, Ashfield Meetings & Events
There has been a myriad of reasons over the past few years to safely assume the popularity and perceived worth of face-to-face medical meetings was well and truly on the decline – from advances in technology, to funding challenges.
Separate, yet complementary studies looking at global HCP preferences reveals that the medical meeting is in fact their preferred channel for scientific communications.
Yet a 2018 study by Ashfield looking at global HCP preferences reveals that the medical meeting is in fact their preferred channel for scientific communications.
Furthermore, HCPs exhibit consumer behaviours in selecting and attending events – which means that while these conferences offer potential engagement riches, they have to offer a specific mix of focus, value and ROI to be successful. To analyse this situation, discuss the learnings from the research and offer guidance on what a modern medical meeting needs to be we present an exclusive debate.
Bringing together experts from Ashfield Meetings & Events and the European Society of Cardiology our panel will discuss:
1. Findings from the 2018 Ashfield Science of HCP Meetings research and whitepaper
2. How HCPs want to engage with pharma and scientific communications
3. What works? How to create the events that HCPs want to attend
4. The future of meetings - balancing face to face and digital
5. How HCPs determine whether a meeting is likely to be worth the investment
6. Strategies and tactics for planners and meeting stakeholders to implement to continue to add value for HCPs attending medical meetings